Literature DB >> 15280773

Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D.

Boris Renjifo1, Peter Gilbert, Beth Chaplin, Gernard Msamanga, Davis Mwakagile, Wafaie Fawzi, Max Essex.   

Abstract

OBJECTIVE: To determine whether different HIV-1 genotypes present in a single cohort, in Dar es Salaam, Tanzania, showed differences in timing for transmission from mothers to their infants.
METHODS: We determined the maternal viral load, transmission time, and the HIV-1 envelope (env) subtype of 253 HIV-1-infected infants enrolled in a randomized double-blind placebo-controlled trial to examine the efficacy of vitamins in decreasing mother-to-child transmission in Tanzania. Classification of HIV-1 positivity in utero was based on PCR results at birth. Infants were classified as intrapartum infected if they scored negative for the sample collected at birth and positive for the sample collected at 6 weeks of age.
RESULTS: We found significant differences in the distribution of transmission time according to subtype. A higher proportion of HIV-1 with subtype C env (C-env) was transmitted in utero than HIV-1 with subtype A env (A-env), subtype D env (D-env), or both combined.
CONCLUSIONS: The identification of patterns of mother-to-child transmission times among HIV-1 genotypes may be useful in the selection of drug regimens for chemoprophylaxis. Based on our results, the efficacy of regimens administered only at labor may not protect as large a fraction of infants born in geographical regions with subtype C-env epidemics as compared to epidemics in regions where subtypes A-env and D-env predominate in the population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280773     DOI: 10.1097/01.aids.0000131392.68597.34

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  45 in total

1.  Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.

Authors:  Philip L Bulterys; Sudeb C Dalai; David A Katzenstein
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

Review 2.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Magdalena E Sobieszczyk; Francine E McCutchan; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

3.  Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns.

Authors:  A Waléria-Aleixo; A N Martins; M B Arruda; R M Brindeiro; R M Da-Silva; F F Nobre; D B Greco; A Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

4.  Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.

Authors:  Marion W Kiguoya; Jaclyn K Mann; Denis Chopera; Kamini Gounder; Guinevere Q Lee; Peter W Hunt; Jeffrey N Martin; T Blake Ball; Joshua Kimani; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

6.  Increasing HIV subtype diversity and its clinical implications in a sentinel North American population.

Authors:  Reed Ac Siemieniuk; Brenda Beckthold; M John Gill
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

7.  CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Authors:  Awet Abraha; Immaculate L Nankya; Richard Gibson; Korey Demers; Denis M Tebit; Elizabeth Johnston; David Katzenstein; Asna Siddiqui; Carolina Herrera; Lucia Fischetti; Robin J Shattock; Eric J Arts
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.

Authors:  Ana T Dumans; Cláudia C Barreto; André F Santos; Mônica Arruda; Thatiana M Sousa; Elizabeth S Machado; Ester C Sabino; Rodrigo M Brindeiro; Amílcar Tanuri; Alberto J Duarte; Marcelo A Soares
Journal:  Infect Genet Evol       Date:  2008-10-17       Impact factor: 3.342

9.  Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.

Authors:  Sergey Iordanskiy; Mackenzie Waltke; Yanjun Feng; Charles Wood
Journal:  Retrovirology       Date:  2010-10-12       Impact factor: 4.602

Review 10.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.